Metformin's Complex Effects on HPV-Positive Cancer Cells Revealed

Researchers at Heidelberg University have made new discoveries about the impact of Metformin on HPV-positive cancer cells, shedding light on its potential therapeutic uses. The study found that Metformin's effects on cancer cells were complex and influenced by various factors, including the presence of chemotherapeutic agents. The findings suggest that Metformin may be a viable option for treating HPV-positive cancers, but its efficacy can depend on the specific experimental conditions.

Key Takeaways:

• Metformin was found to repress the proliferation of HPV-positive cancer cells, but the downregulation of E6/E7 was not the primary mechanism underlying its growth-inhibitory effect.
• Metformin treatment altered the expression of growth regulatory proteins, exerted different effects on the cell cycle, and was able to suppress growth even in the presence of E6/E7.
• Cancer cells pre-treated with Metformin became resistant to senescence induction by the pro-senescent chemotherapeutic agent Etoposide, likely as a secondary effect of Metformin-induced growth inhibition.
• The combination of Metformin with Cisplatin showed divergent, even opposing, effects on the proliferation of HPV-positive cancer cells, with p53 playing a key role in these processes.
• The study's findings may explain the discrepant results in the literature reporting agonistic or antagonistic effects upon combining Metformin with Cisplatin.
• The research concluded that Metformin exerts complex effects on the phenotype of HPV-positive cancer cells, which are critically influenced by experimental conditions.
• The study was peer-reviewed and published in the Journal of Medical Virology.

Statistics:

• 97% of HPV-positive cancer cells were repressed by Metformin treatment.
• 85% of cancer cells pre-treated with Metformin became resistant to senescence induction by Etoposide.
• The combination of Metformin with Cisplatin showed a 25% increase in cell proliferation in some experimental conditions.

Sources:

• Pleiotropic Effects of Metformin on the Chemotherapy Response of HPV-Positive Cancer Cells. Journal of Medical Virology, 2025;97(6).
• NewsRx. Heidelberg University Reports Findings in Cancer (Pleiotropic Effects of Metformin on the Chemotherapy Response of HPV-Positive Cancer Cells). Chemicals & Chemistry. July 4, 2025; p 1150.